Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO
Filter by Topic
ASCO 2014 Highlights
ASCO 2014 – Colorectal and Head & Neck Cancer
ASCO 2014 – Immuno-Oncology
ASCO 2014 – Lung Cancer
ASCO 2015 - Lung Cancer
ASCO 2015 Highlights
ASCO 2016 – Lung Cancer
ASCO 2017 – Multiple Myeloma
ASCO 2018 Insights
ASCO 2019
ASCO 2020 Cholangiocarcinoma
ASCO Breast Cancer Symposium
ASCO Quality Care Symposium
ASCO’s 1st Quality Care Symposium
Erlotinib Plus Bevacizumab as First-Line Treatment for EGFR+, Advanced NSCLC
ASCO 2014 – Lung Cancer
,
ASCO
Conference Correspondent
Read Article
Adjuvant Ipilimumab for Patients with High-Risk Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
First Trial Assessing Nivolumab in Platinum-Resistant Ovarian Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Phase 2 Trial of Nivolumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Phase 2 Trial of Nivolumab and VEGF Inhibitors in First-Line Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
MPDL3280A, an Anti-PD-L1 Monoclonal Antibody, in Metastatic Bladder Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Chemotherapy Plus Bevacizumab or Cetuximab in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Racial Differences in KRAS/BRAF Mutation Rates and Survival in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Early Predictors of Overall Survival in mCRC
ASCO 2014 – Colorectal and Head & Neck Cancer
,
ASCO
Conference Correspondent
Read Article
Page 12 of 19
7
8
9
10
11
12
13
14
15
16
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma